摘要
目的研究盐酸二甲双胍缓释胶囊的药动学和相对生物利用度。方法20名健康男性志愿者随机、交叉单剂量和多剂量口服盐酸二甲双胍缓释胶囊和普通片1000mg,采用高效液相色谱法测定其血药浓度,计算各药动学参数和相对生物利用度。结果20名健康志愿者单次po盐酸二甲双胍缓释片和普通片1000mg的主要药动学参数pmax分别为:(1.27±0.32)和(1.82±0.32)mg·L^-1;tmax分别为(5.0±1.62)和(2.95±0.72)h;AuC0~∞(13.53±3.87)和(12.36±2.24)mg·h·L^-1;AuC0~∞(14.44±4.09)和(12.66±2.34)mg·h·L^-1,相对生物利用度(F)为(109.62±26.81)%。多次po盐酸二甲双胍缓释胶囊和普通片的主要药动学参数分别为:pmax(0.10±0.05)和(0.33±0.09)mg·L^-1;AUCss(12.28±2.73)和(8.59±2.01)mg·h·L^-1;DF(239.68±30.98)%和(118.68±22.34)%,相对生物利用度(F)为(72.82±11.37)%。结论AUC经方差分析和双单侧t检验,两制荆具有生物等效性。pmax经检验不具等效性,tmax经非参数检验有显著性差异(P〈O.05),受试缓释胶囊较参比普通片的pmax、tmax有所延长,表明受试制剂具有缓释特性。
OBJECTIVE To study pharmacokinetics and relative bioavailability of mefformin hydroehloride sustained release capsule in healthy volunteers, METHODS The serum concentrations of 20 volunteers were determined by HPLC after a single and multiple oral doses of 1 000 mg of mefformin hydroehlofide capsule or reference mefformin hydrochloride tablet in a randomized crossover design study. The pharmacokinetic parameters were calculated and the relative bioavailability and bioequivalence of two formulations were evaluated. RESULTS The pharmacokinetic parameters for test and reference drugs after a single oral dose were as follows: pmax ( 1.27 ± 0.32) and ( 1.82 ± 0.32) mg· L^-1; toad(5.0 ± 1.62)and(2.95 ± 0.72)h; AUC0-∞ (13.53 ± 3.87)and (12.36.± 2.24) mg·h·L^-1 ;AUC0-∞ (14.44 ± 4.09) and (12.66 ± 2.34) mg·h·L^-1, respectively. The relative bioavailability of the test preparation was( 109.62 ± 26.81 ) %. The pharmacokinetic parameters for test and reference preparations after multiple oral doses were as follows: pmin,(0.10 ± 0.05) and (0.33 ± 0.09)mg·L^-1; AUCss( 12.28 ± 2.73) and (8.59 ± 2.01) mgmg·h·L^-1; DF(239.68 ± 30.98)% and (1118.68 ± 22.34)%. The relative bioavailability was(72.82 ± 11.37)%. CONCLUSION The Pmax of meffonnin sustained release capsules is lower and tmax is longer than those of regular ones. The results indicate that two formulations are bio-equivalent.
出处
《中国药学杂志》
CAS
CSCD
北大核心
2006年第20期1579-1582,共4页
Chinese Pharmaceutical Journal